Prescribing Newsletter
Fluoroquinolone antibiotics – Safety Concerns
Fluoroquinolone antibiotics, such as ciprofloxacin, have a limited place in NICE & Public Health England guidance on managing common infections. […]
SGLT2 inhibitors – reports of Fournier’s gangrene
The MHRA have provided the following advice arising from reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum) […]
Carbimazole – Stronger Advice on Contraception
The MHRA has strengthened advice for healthcare professionals on contraception requirements for women with childbearing potential prescribed carbimazole. The stronger […]
Yellow Card App – Updated & Improved
The MHRA have updated and improved the Yellow Card App for iOS and Android. The App allows users to: Report suspected […]
Tapentadol – Risk of Seizures & Serotonin Syndrome
Following an EU-wide review of safety data and spontaneous reports of serious adverse events, European & UK regulators have strengthened warnings […]
Supply Issues in Primary Care – Update January 2019
The Department of Health & Social Care (DHSC) Medicines Supply team have published the latest update on medicines supply issues […]
Medicines Supply Continuity – Update on No Deal EU Exit Contingency Plans
The Chief Pharmaceutical Officer for England has written to pharmacists working in and with the NHS in England to update […]
Getting Medication – Government Statement
The Department of Health & Social Care have published a policy paper on access to medicines in the UK – […]
UKMi Q&A via SPS – New Resources
UKMi publish a series of Q&A documents on the NHS SPS website, with summaries of high quality, evidence-based, and quality controlled […]